Cargando…
The Role of Antibody-Based Therapies in Neuro-Oncology
This review explores the evolving landscape of antibody-based therapies in neuro-oncology, in particular, immune checkpoint inhibitors and immunomodulatory antibodies. We discuss their mechanisms of action, blood-brain barrier (BBB) penetration, and experience in neuro-oncological conditions. Eviden...
Autores principales: | Ramapriyan, Rishab, Sun, Jing, Curry, Annabel, Richardson, Leland G., Ramesh, Tarun, Gaffey, Matthew A., Gedeon, Patrick C., Gerstner, Elizabeth R., Curry, William T., Choi, Bryan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660525/ https://www.ncbi.nlm.nih.gov/pubmed/37987252 http://dx.doi.org/10.3390/antib12040074 |
Ejemplares similares
-
(R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas
por: Richardson, Leland G., et al.
Publicado: (2019) -
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
por: Schmidts, Andrea, et al.
Publicado: (2022) -
Imaging in neuro-oncology
por: Nandu, Hari, et al.
Publicado: (2018) -
Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey
por: Rogers, James L, et al.
Publicado: (2020) -
Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier
por: Lampson, Lois A
Publicado: (2011)